DK1513531T3 - Basisk non-peptide bradykinin antagonister og farmaceutiske sammensætninger deraf - Google Patents
Basisk non-peptide bradykinin antagonister og farmaceutiske sammensætninger derafInfo
- Publication number
- DK1513531T3 DK1513531T3 DK03757025.6T DK03757025T DK1513531T3 DK 1513531 T3 DK1513531 T3 DK 1513531T3 DK 03757025 T DK03757025 T DK 03757025T DK 1513531 T3 DK1513531 T3 DK 1513531T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- basic non
- bradykinin antagonists
- peptide bradykinin
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001247A ITMI20021247A1 (it) | 2002-06-07 | 2002-06-07 | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
PCT/EP2003/005893 WO2003103671A1 (en) | 2002-06-07 | 2003-06-05 | Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1513531T3 true DK1513531T3 (da) | 2010-01-18 |
Family
ID=29727266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03757025.6T DK1513531T3 (da) | 2002-06-07 | 2003-06-05 | Basisk non-peptide bradykinin antagonister og farmaceutiske sammensætninger deraf |
Country Status (23)
Country | Link |
---|---|
US (1) | US7491825B2 (da) |
EP (1) | EP1513531B1 (da) |
JP (1) | JP4293988B2 (da) |
CN (1) | CN1658877B (da) |
AR (1) | AR040443A1 (da) |
AT (1) | ATE446091T1 (da) |
AU (1) | AU2003242628A1 (da) |
BR (1) | BR0311825A (da) |
CA (1) | CA2488565C (da) |
CY (1) | CY1109543T1 (da) |
DE (1) | DE60329755D1 (da) |
DK (1) | DK1513531T3 (da) |
EG (1) | EG26672A (da) |
ES (1) | ES2332509T3 (da) |
IT (1) | ITMI20021247A1 (da) |
MX (1) | MXPA04012193A (da) |
PL (1) | PL224990B1 (da) |
PT (1) | PT1513531E (da) |
RU (1) | RU2327688C2 (da) |
SA (1) | SA03240198B1 (da) |
SI (1) | SI1513531T1 (da) |
TW (1) | TWI315983B (da) |
WO (1) | WO2003103671A1 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1490062T3 (da) * | 2002-03-26 | 2008-04-28 | Boehringer Ingelheim Pharma | Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf |
BR0313923A (pt) * | 2002-08-29 | 2005-07-12 | Boehringer Ingelheim Pharma | Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas |
UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
US7795272B2 (en) * | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
ITMI20041963A1 (it) * | 2004-10-15 | 2005-01-15 | Luso Farmaco Inst | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
JP2008525525A (ja) * | 2004-12-27 | 2008-07-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメティクス、その製法、医薬組成物及び使用 |
WO2007115805A2 (en) * | 2006-04-05 | 2007-10-18 | European Molecular Biology Laboratory (Embl) | Aurora kinase inhibitors |
WO2008046573A1 (de) * | 2006-10-16 | 2008-04-24 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
JP2010512331A (ja) * | 2006-12-06 | 2010-04-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルココルチコイド模倣薬、それらの製造方法、医薬組成物、及びこれらの使用 |
TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽b2受體調節劑 |
EP2136634A4 (en) * | 2007-04-10 | 2011-07-06 | Boehringer Ingelheim Int | MIMETIC GLUCOCORTICOID SUBSTANCES, PREPARATION METHODS THEREOF, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF |
ITMI20072225A1 (it) * | 2007-11-23 | 2009-05-24 | Luso Farmaco Inst | "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso" |
US8268859B2 (en) * | 2008-06-06 | 2012-09-18 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
IT1391236B1 (it) * | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso |
AU2018371186B2 (en) | 2017-11-24 | 2022-05-12 | Pharvaris Netherlands B.V. | Novel bradykinin B2 receptor antagonists |
UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
WO2023180575A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽b2受體拮抗劑之固態延長釋放組成物 |
WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2735128B1 (fr) * | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
DE19609827A1 (de) | 1996-03-13 | 1997-09-18 | Hoechst Ag | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
DE19610784A1 (de) | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
FR2751650B1 (fr) | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
FR2756562B1 (fr) | 1996-12-04 | 1999-01-08 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
-
2002
- 2002-06-07 IT IT2002MI001247A patent/ITMI20021247A1/it unknown
-
2003
- 2003-06-04 EG EG2003060535A patent/EG26672A/en active
- 2003-06-05 WO PCT/EP2003/005893 patent/WO2003103671A1/en active Application Filing
- 2003-06-05 PL PL373466A patent/PL224990B1/pl unknown
- 2003-06-05 MX MXPA04012193A patent/MXPA04012193A/es active IP Right Grant
- 2003-06-05 DK DK03757025.6T patent/DK1513531T3/da active
- 2003-06-05 RU RU2004135567/04A patent/RU2327688C2/ru not_active IP Right Cessation
- 2003-06-05 AT AT03757025T patent/ATE446091T1/de active
- 2003-06-05 TW TW092115212A patent/TWI315983B/zh not_active IP Right Cessation
- 2003-06-05 SI SI200331698T patent/SI1513531T1/sl unknown
- 2003-06-05 DE DE60329755T patent/DE60329755D1/de not_active Expired - Lifetime
- 2003-06-05 US US10/516,681 patent/US7491825B2/en not_active Expired - Fee Related
- 2003-06-05 CN CN038130270A patent/CN1658877B/zh not_active Expired - Fee Related
- 2003-06-05 AR AR20030102009A patent/AR040443A1/es not_active Application Discontinuation
- 2003-06-05 CA CA2488565A patent/CA2488565C/en not_active Expired - Fee Related
- 2003-06-05 PT PT03757025T patent/PT1513531E/pt unknown
- 2003-06-05 JP JP2004510790A patent/JP4293988B2/ja not_active Expired - Fee Related
- 2003-06-05 ES ES03757025T patent/ES2332509T3/es not_active Expired - Lifetime
- 2003-06-05 EP EP03757025A patent/EP1513531B1/en not_active Expired - Lifetime
- 2003-06-05 AU AU2003242628A patent/AU2003242628A1/en not_active Abandoned
- 2003-06-05 BR BR0311825-8A patent/BR0311825A/pt not_active Application Discontinuation
- 2003-07-12 SA SA3240198A patent/SA03240198B1/ar unknown
-
2009
- 2009-12-03 CY CY20091101272T patent/CY1109543T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TW200400819A (en) | 2004-01-16 |
US7491825B2 (en) | 2009-02-17 |
ITMI20021247A1 (it) | 2003-12-09 |
EP1513531B1 (en) | 2009-10-21 |
PL373466A1 (en) | 2005-09-05 |
ATE446091T1 (de) | 2009-11-15 |
MXPA04012193A (es) | 2005-02-25 |
EG26672A (en) | 2014-05-13 |
CN1658877B (zh) | 2010-04-28 |
RU2327688C2 (ru) | 2008-06-27 |
CY1109543T1 (el) | 2014-08-13 |
SI1513531T1 (sl) | 2010-01-29 |
EP1513531A1 (en) | 2005-03-16 |
PL224990B1 (pl) | 2017-02-28 |
JP4293988B2 (ja) | 2009-07-08 |
TWI315983B (en) | 2009-10-21 |
AU2003242628A1 (en) | 2003-12-22 |
WO2003103671A8 (en) | 2004-12-29 |
CN1658877A (zh) | 2005-08-24 |
PT1513531E (pt) | 2009-12-17 |
ES2332509T3 (es) | 2010-02-08 |
SA03240198B1 (ar) | 2009-12-08 |
RU2004135567A (ru) | 2005-07-20 |
WO2003103671A1 (en) | 2003-12-18 |
CA2488565A1 (en) | 2003-12-18 |
US20060205712A1 (en) | 2006-09-14 |
DE60329755D1 (de) | 2009-12-03 |
AR040443A1 (es) | 2005-04-06 |
BR0311825A (pt) | 2005-03-15 |
JP2005532354A (ja) | 2005-10-27 |
CA2488565C (en) | 2012-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1513531T3 (da) | Basisk non-peptide bradykinin antagonister og farmaceutiske sammensætninger deraf | |
DK1799214T3 (da) | Ikke-peptid-bradykinin-antagonister og famaceutiske sammensætninger heraf | |
IS7948A (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
DK1575618T3 (da) | Dispergerbare farmaceutiske kombinationer | |
DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
DK1517617T3 (da) | Komprimattyggegummi | |
ATE390426T1 (de) | Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate | |
DK1354873T3 (da) | Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
DK1425019T3 (da) | Farmaceutisk sammensætning omfattende et androgen | |
DK1554250T3 (da) | Hidtil ukendt lactamer og anvendelser deraf | |
IS2463B (is) | Útskipt díketópíperasín og notkun þeirra sem oxytósínmótlyfja | |
DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
FI20031078A0 (fi) | Antibioottisesti oletiivisia farmaseuttisia koostumuksia | |
NO20033162L (no) | Farmasöytisk tablett omfattende paroksetinmesylat | |
DK1482967T3 (da) | Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1 | |
DK1680134T3 (da) | Sammensætninger og anvendelser deraf | |
ITMI20020926A1 (it) | Composizioni farmaceutiche riepitelizzanti | |
SE0201660D0 (sv) | Pharmaceutical formulation | |
DOP2002000508A (es) | Composición farmaceutica | |
ITMI20021127A0 (it) | Composizioni farmaceutiche oromucosali | |
SE0203829D0 (sv) | Novel lactams and uses thereof | |
FI5308U1 (fi) | Nurkkatolppa | |
DE60200783D1 (de) | Modulares Gerät | |
ITBA20030005A1 (it) | Dispositivo modulare di segnalazione e rilevazione di |